DOMS Industries Ltd Q2 FY27 Earnings Call: Reaffirms 18-20% Growth Guidance, Rs. 300+ Cr Capex Underway

DOMS Industries Ltd held its Q2 FY27 earnings call on November 02, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Volume-led growth despite flood disruption and cost inflation

• Q2 FY 2026-2027 revenue of Rs.667.8 Cr, +17.6% YoY — H1 FY 2026-2027 revenue grew 18.4%, driven by volume-led growth across domestic and export markets, capacity additions, new launches and calibrated pricing. CFO Rahul Shah attributed ~80%+ of Q2 growth to volumes and ~20% to realizations.
• EBITDA of Rs.82.8 Cr in Q2 (12.4% margin) — H1 FY 2026-2027 EBITDA at Rs.165.3 Cr, also at 12.4%; margins held sequentially as consumption margin gains were offset by higher manpower costs, with raw material prices rising significantly in the second half of Q2 FY 2026-2027.
• PAT of Rs.38.3 Cr (5.7% margin) in Q2 — H1 FY 2026-2027 PAT of Rs.83.6 Cr (6.2% margin), including a one-time exceptional loss of Rs.10.4 Cr from heavy rainfall/flooding in Gujarat; insurance claims have been lodged and recovery is expected to substantially offset the impact.
• Gujarat flooding cost ~300-350 bps of sales growth — management estimated the impact during Q1 FY27 via inventory damages and workforce mobility challenges affecting production and sales.
• Working capital cycle held within 55-60 days in H1 FY 2026-2027 — management emphasized growth quality over extended credit terms, with inventories marginally higher on carrying costs and continued payables discipline.
• Broad-based category growth in Q2 FY 2026-2027 — scholastic stationery, scholastic art material and office supplies grew; kits & combo grew marginally on capacity constraints; hobby & craft momentum on an expanded adhesives range; hygiene supported by improved diaper sales on favorable climatic conditions.

~15% input inflation; patience over Q3-Q4 FY27 before significant action

• Input cost inflation pegged at ~15% for Q2 FY27 — at a ~60% consumption level, the P&L impact was ~9% in Q2 FY 2026-2027, a ~2% improvement versus Q1 FY 2026-2027 (when the consumption impact was ~10%).
• Polymer prices at their peak since the start of the West Asian conflict — prices cooled in H1 of Q2, rose substantially from early-to-mid August 2026, increased further in October (Q3 FY 2026-2027), with polymer increases now occurring roughly once or twice a week.
• Targeted EBITDA margin range of 16-17% (period unspecified) — management will remain patient over the next couple of quarters, evaluating strategic price increases and operating measures; explicitly not a commitment to margin recovery in any particular quarter. Consolidated EBITDA margins were close to 17% before West Asia conflict-driven inflation, and management wants to return to that level once conditions normalize (period unspecified); long-term guidance of 15-17% was cited in Q&A.
• Three-scenario framework for Q3-Q4 FY 2026-2027 — if prices stay at current levels, required actions are known; if prices decline and stabilize, pricing actions may not be required; if prices keep rising, more significant action will be required — actions "can be significant, it can be aggressive."
• 3-4 month price-transmission lag — with ~2-month packing material inventory, recent cost increases cannot yet be fully passed through; pricing response is granular (product-wise cost sheets, MRP/channel increases, reduced schemes), with schemes and discounts down vs the previous year.
• Past cycles took ~18-24 months to fully capture inflation — management noted this is company-specific, not industry-wide; the current cycle has persisted ~two quarters (Q1-Q2 FY 2026-2027), with a couple more quarters of patience (through roughly Q4 FY 2026-2027) before required actions, followed by another one-odd year for the build-up.
• Management declined to provide margin or cash-flow visibility given macroeconomic uncertainty, with everyone awaiting the outcome of the midterm elections and its impact on crude.

Reynolds ramp-up underway; Rs.300+ Cr capex across FY 2026-2027

• First building of the 50-acre greenfield commissioned — ~170,000 sq ft added, dedicated to office supplies (primarily Reynolds-brand pen manufacturing); commercial production started for fast-moving SKUs Bright and 045, with trial production underway for the Jetter click pen.
• Reynolds revenue expected from Q3 FY 2026-2027 — gaining momentum in Q4 FY 2026-2027; pre-acquisition, Reynolds generated ~Rs.150 Cr of writing-instruments revenue, and management committed to compressing the timeline to reach that level — "if it is going to take probably one year, then we'll ensure it happens in nine months" (i.e., within FY 2027-2028).
• Reynolds team integration added 0.5-1% of quarterly sales to employee cost in Q2 FY 2026-2027 — the entire Reynolds sales and support team joined effective July 1; the temporary cost-revenue mismatch weighed on Q2 profitability and is expected to normalize as operations scale up. Note: the deal covered only identified Reynolds assets (molds and assembly machines) shipped from Chennai to Umargam; Reynolds adds no fresh capacity, so FY 2026-2027 revenue guidance is maintained at 18-20%.
• Reynolds positioned in the Rs.10 to under Rs.100 mid-to-early premium band — management acquired the brand to build a strong second brand in writing instruments; MRP kept unchanged for now, treating it as a new-product launch.
• Over Rs.200 Cr capex in H1 FY 2026-2027 — a further Rs.100-125 Cr planned for the remainder of FY 2026-2027 (Rs.100-150 Cr cited in another response for H2 FY27), covering the greenfield project, land expansion from 45 to 50 acres, plant & machinery, and the Reynolds asset purchase.
• Second and third greenfield buildings in machinery installation — adding wooden pencil and office supplies capacity, with wooden pencil capacity and further office supplies expansion expected before the close of FY 2026-2027; three other buildings at finishing stage with flexible end-use pending demand assessment.
• Writing instruments right-to-win is product-led — the first ballpoint pen with refills launched in June 2023 and volumes scaled rapidly; DOMS claims one of the largest molding setups in the stationery space (probably globally) and is installing its own tip manufacturing facilities for backward integration, with benefits to be passed to the channel/consumer rather than retained as margin.

Uniclan margins compressed on crude-linked inputs; 7SPA JV in formation

• Uniclan revenue grew 21.5% YoY in Q2 FY 2026-2027 — a mix of volume growth and selling-price increases; diapers are crude-sensitive and part of the raw-material inflation was passed on to consumers, while consumption was impacted versus the year-ago period.
• Uniclan EBITDA margin fell to 6.4% from 8.1% in Q2 FY 2025-2026 — primarily on higher raw-material prices; management wants margins of around 8-10% for this segment in the longer term (period unspecified) and will take a call on further price increases as things normalize.
• No further Uniclan capex until optimal utilization — an additional baby-diaper line and a new wet-wipes line (installed post-acquisition) are in production with spare capacity; current infrastructure expected to cover growth for FY 2027-2028, with a capex evaluation alongside Uniclan's promoters at the beginning of FY 2027-2028 on whether investment is required to fund growth for FY 2028-29.
• DOMS 7 Private Limited incorporated in the third week of October 2026 (Q3 FY27) — as a wholly owned subsidiary; 7SPA will eventually become a 50% partner (period unspecified).
• 7SPA documentation at the apostille stage with the Indian consulate in Italy — the joint venture agreement is being finalized in parallel; the DOMS Kido and Seven teams will finalize the business plan only after participation is formalized, following which details will be shared.
• Skido clarified as not a standalone brand — all products manufactured and sold by Skido carry the DOMS brand, and all Skido branded sales are reported under the DOMS brand.

Debt nearly doubled to ~Rs.200 Cr on growth capex

• Debt rose to about Rs.200 Cr as of Q2 FY 2026-2027 — up from March 2026 (FY 2025-2026 year-end) levels, driven by debt-funded capacity capex after IPO funds were utilized in April FY 2026-2027, the Reynolds acquisition outflow, higher working capital needs, and temporarily lower free cash flow from margin compression.
• Management views the debt increase as a strategic investment in growth — the balance sheet remains healthy with disciplined capital allocation; debt may rise further during the ongoing capital investment cycle, with a significant portion of future expansion expected to be funded by internal accruals once things normalize.
• At least ~Rs.100-120 Cr of debt required in the medium term — to fund ongoing capex (period unspecified beyond "midterm"); this requirement could come down if cash flow generation returns to earlier levels sooner than expected.
• Management did not confirm the analyst's suggestion that free cash flow would normalize from FY 2027-2028 — citing limited visibility on how margins and hence free cash flow pan out.

FY27 guidance reaffirmed at 18-20%; FY28 outlook deferred to early 2027

• Consolidated sales growth of 18-20% reaffirmed for FY 2026-2027 — anchored in capacity additions across office supplies, adhesives and paper stationery, with a positive demand environment across key categories and markets; the target of sustaining 18-20% growth "in the near to midterm" was also affirmed.
• Paper stationery seen driving significant growth over the rest of H2 FY 2026-2027 — with the back-to-school season building from Q3 FY 2026-2027; all categories, including scholastic art material (wooden color pencil capacity) and newly launched school/compass boxes, are seeing positive momentum.
• Greenfield segments to benefit revenue growth over the next 12-18 months — writing instruments capacity first, followed by pencils (spanning scholastic stationery and scholastic art) and other office supplies items, extending through FY 2027-2028 into early FY 2028-2029.
• FY 2027-2028 growth question deferred to January-February 2027 — asked whether FY 2027-2028 revenue growth could fall below 18-20% if selling prices are cut after raw materials revert to pre-war levels post Q3 FY 2026-2027, management deferred a detailed answer pending clarity on the inflation cycle and on capacity deployment by end of FY 2026-2027 whose benefits would accrue in FY 2027-2028.
• West region slowdown is optical, not structural — West optics are skewed by sales to Bangladesh routed through Mumbai-based merchant exporters, hit by the geopolitical situation in Bangladesh; general trade consumption data shows the brand equally spread across all four regions, with more headroom in southern and eastern markets.
• Margin recovery timing remains open — management rejected the framing that pens/baby hygiene carry structurally higher margins (baby hygiene is an 8-10% EBITDA margin category; all other categories have a similar profile), reiterating the philosophy: "nothing at the cost of market, nothing at the cost of margin."